Download Files:
Products Details
Product Description
– BTK-IN-20 (compound 283) is a BTK tyrosine kinase inhibitor and a 1H-pyrazolo[3,4-d]pyrimidine derivative. BTK-IN-20 can be used for the research of cancer and inflammation[1].
Web ID
– HY-148832
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C30H30FN7O2
References
– [1]Goldstein, David Michael. Preparation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as tyrosine kinase inhibitors. US8673925. 2014.
CAS Number
– 1581714-50-2
Molecular Weight
– 539.60
SMILES
– NC1=C(C(C2=CC=C(OC3=CC=CC=C3)C=C2F)=NN4[C@H]5CN(C(/C(C#N)=CC(C)(C)C)=O)CCC5)C4=NC=N1
Clinical Information
– No Development Reported
Research Area
– Cancer; Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– Btk
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
